Glycostem Therapeutics
Biotechnology ResearchNetherlands11-50 Employees
Glycostem Therapeutics is a Dutch biotech company established in 2007. Glycostem Therapeutics has developed the world's first GMP compliant NK cell platform that is ready for industrial scale-up.